asparagine has been researched along with Hyperaldosteronism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardin, S; Baudrie, V; Bernstein, KE; Billet, S; Clauser, E; Conchon, S; Corvol, P; Elghozi, JL; Escoubet, B; Gasc, JM; Hamard, G; Michaud, A; Muffat-Joly, M; Souil, E; Verp, S | 1 |
| Distler, A; Nast, HP; Schreiber, G; Walter, U | 1 |
| Dramburg, M; Henneberg, U | 1 |
3 other study(ies) available for asparagine and Hyperaldosteronism
| Article | Year |
|---|---|
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.
Topics: Angiotensins; Animals; Asparagine; Blood Pressure; Cardiovascular Diseases; Disease Progression; Female; Fibrosis; Gene Expression Regulation; Hyperaldosteronism; Hypertension; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Receptor, Angiotensin, Type 1; Renin; Signal Transduction | 2007 |
[Inactivation of alpha-L-asparaginyl-angiotensin II by erythrocytes from healthy persons, and from patients with various forms of hypertension, or liver diseases].
Topics: Adult; Aminopeptidases; Angiotensin II; Asparagine; Cell Membrane; Endopeptidases; Erythrocytes; Female; Hemolysis; Humans; Hyperaldosteronism; Hypertension, Malignant; Hypertension, Renal; Liver Diseases; Male; Middle Aged | 1974 |
[Clinical studies on treatment of postoperative intestinal atonia].
Topics: Aortic Diseases; Asparagine; Dextrans; Humans; Hyperaldosteronism; Injections, Intramuscular; Intestinal Diseases; Mineralocorticoid Receptor Antagonists; Muscle Tonus; Parasympathomimetics; Postoperative Complications | 1974 |